Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series.
Campochiaro C, Farina N, Tomelleri A, Ferrara R, Lazzari C, De Luca G, Bulotta A, Signorelli D, Palmisano A, Vignale D, Peretto G, Sala S, Esposito A, Garassino M, Gregorc V, Dagna L.
Campochiaro C, et al. Among authors: gregorc v.
Eur J Intern Med. 2021 Nov;93:87-94. doi: 10.1016/j.ejim.2021.07.016. Epub 2021 Aug 12.
Eur J Intern Med. 2021.
PMID: 34391591